These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35379250)

  • 1. CoronaVac vaccine is effective in preventing symptomatic and severe COVID-19 in pregnant women in Brazil: a test-negative case-control study.
    Paixao ES; Wong KLM; Alves FJO; de Araújo Oliveira V; Cerqueira-Silva T; Júnior JB; Machado TM; Junior EPP; Boaventura VS; Penna GO; Werneck GL; Rodrigues LC; Pearce N; Barreto ML; Barral-Netto M
    BMC Med; 2022 Apr; 20(1):146. PubMed ID: 35379250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study.
    Ranzani OT; Hitchings MDT; Dorion M; D'Agostini TL; de Paula RC; de Paula OFP; Villela EFM; Torres MSS; de Oliveira SB; Schulz W; Almiron M; Said R; de Oliveira RD; Vieira da Silva P; de Araújo WN; Gorinchteyn JC; Andrews JR; Cummings DAT; Ko AI; Croda J
    BMJ; 2021 Aug; 374():n2015. PubMed ID: 34417194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes.
    Buchan SA; Chung H; Brown KA; Austin PC; Fell DB; Gubbay JB; Nasreen S; Schwartz KL; Sundaram ME; Tadrous M; Wilson K; Wilson SE; Kwong JC
    JAMA Netw Open; 2022 Sep; 5(9):e2232760. PubMed ID: 36136332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change in covid-19 risk over time following vaccination with CoronaVac: test negative case-control study.
    Hitchings MDT; Ranzani OT; Lind ML; Dorion M; D'Agostini TL; de Paula RC; de Paula OFP; de Moura Villela EF; Scaramuzzini Torres MS; de Oliveira SB; Schulz W; Almiron M; Said R; de Oliveira RD; Vieira da Silva P; de Araújo WN; Gorinchteyn JC; Dean NE; Andrews JR; Cummings DAT; Ko AI; Croda J
    BMJ; 2022 Jun; 377():e070102. PubMed ID: 35697361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 Gamma variant transmission in Manaus, Brazil: A test-negative case-control study.
    Hitchings MDT; Ranzani OT; Torres MSS; de Oliveira SB; Almiron M; Said R; Borg R; Schulz WL; de Oliveira RD; da Silva PV; de Castro DB; Sampaio VS; de Albuquerque BC; Ramos TCA; Fraxe SHH; da Costa CF; Naveca FG; Siqueira AM; de Araújo WN; Andrews JR; Cummings DAT; Ko AI; Croda J
    Lancet Reg Health Am; 2021 Sep; 1():100025. PubMed ID: 34386791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Population-Based Test-Negative Matched Case-Control Analysis of SARS-CoV-2 Vaccine Effectiveness Among Pregnant People in Ontario, Canada.
    Lapinsky SC; Baxter NN; Sutradhar R; Everett K; Porter J; Kwong JC; Fell DB; Snelgrove JW; Campbell DM; Simpson AN
    J Obstet Gynaecol Can; 2024 Feb; 46(2):102239. PubMed ID: 37839731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of BNT162b2 and CoronaVac vaccines in preventing SARS-CoV-2 Omicron infections, hospitalizations, and severe complications in the pediatric population in Hong Kong: a case-control study.
    Yan VKC; Cheng FWT; Chui CSL; Lai FTT; Wong CKH; Li X; Wan EYF; Wong JSC; Chan EWY; Wong ICK; Kwan MYW; Ip P
    Emerg Microbes Infect; 2023 Dec; 12(1):2185455. PubMed ID: 36852582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of adenovirus type 5 vectored and inactivated COVID-19 vaccines against symptomatic COVID-19, COVID-19 pneumonia, and severe COVID-19 caused by the B.1.617.2 (Delta) variant: Evidence from an outbreak in Yunnan, China, 2021.
    Ma C; Sun W; Tang T; Jia M; Liu Y; Wan Y; Han J; Rodewald L; Li J; Song Y; Wang Y; Wu D; Wang F; Zheng H; Tang L; Gao GF; Yin Z; An Z
    Vaccine; 2022 May; 40(20):2869-2874. PubMed ID: 35400561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of inactivated COVID-19 vaccines against SARS-CoV-2 infections among healthcare personnel in Pakistan: a test-negative case-control study.
    Khan UI; Niaz M; Azam I; Hasan Z; Hassan I; Mahmood SF; Ali A
    BMJ Open; 2023 Jun; 13(6):e071789. PubMed ID: 37369396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing real-life effectiveness of various COVID-19 vaccine regimens during the delta variant-dominant pandemic: a test-negative case-control study.
    Sritipsukho P; Khawcharoenporn T; Siribumrungwong B; Damronglerd P; Suwantarat N; Satdhabudha A; Chaiyakulsil C; Sinlapamongkolkul P; Tangsathapornpong A; Bunjoungmanee P; Nanthapisal S; Tanprasertkul C; Sritipsukho N; Mingmalairak C; Apisarnthanarak A; Tantiyavarong P
    Emerg Microbes Infect; 2022 Dec; 11(1):585-592. PubMed ID: 35114893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The Second Shot of CoronaVac Vaccine May Cause Reduction of Antibody Levels in People who Previously had COVID-19].
    Topkaya AE; Keskin AÜ; Dalan AB; Çıragil P
    Mikrobiyol Bul; 2022 Jan; 56(1):139-142. PubMed ID: 35088968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of an inactivated virus-based SARS-CoV-2 vaccine, BBV152, in India: a test-negative, case-control study.
    Desai D; Khan AR; Soneja M; Mittal A; Naik S; Kodan P; Mandal A; Maher GT; Kumar R; Agarwal A; Gowda NR; H V; Kumar P; Pandey S; Pandey RM; Kumar A; Ray A; Jorwal P; Nischal N; Choudhary A; Brijwal M; Madan K; Lodha R; Sinha S; Dar L; Wig N; Guleria R
    Lancet Infect Dis; 2022 Mar; 22(3):349-356. PubMed ID: 34826383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case-control study.
    Yan VKC; Wan EYF; Ye X; Mok AHY; Lai FTT; Chui CSL; Li X; Wong CKH; Li PH; Ma T; Qin S; Wong VKC; Tsang TC; Tsui SH; Chui WCM; Cowling BJ; Leung GM; Lau CS; Wong ICK; Chan EWY
    Emerg Microbes Infect; 2022 Dec; 11(1):2304-2314. PubMed ID: 35980089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States.
    Turbyfill C; Adams K; Tenforde MW; Murray NL; Gaglani M; Ginde AA; McNeal T; Ghamande S; Douin DJ; Keipp Talbot H; Casey JD; Mohr NM; Zepeski A; Shapiro NI; Gibbs KW; Clark Files D; Hager DN; Shehu A; Prekker ME; Frosch AE; Exline MC; Gong MN; Mohamed A; Johnson NJ; Srinivasan V; Steingrub JS; Peltan ID; Brown SM; Martin ET; Lauring AS; Khan A; Busse LW; Ten Lohuis CC; Duggal A; Wilson JG; June Gordon A; Qadir N; Chang SY; Mallow C; Rivas C; Kwon JH; Halasa N; Chappell JD; Grijalva CG; Rice TW; Stubblefield WB; Baughman A; Rhoads JP; Lindsell CJ; Hart KW; McMorrow M; Surie D; Self WH; Patel MM
    Vaccine; 2022 Nov; 40(48):6979-6986. PubMed ID: 36374708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term effectiveness of inactivated vaccine BBIBP-CorV (Vero Cells) against COVID-19 associated severe and critical hospitalization in Morocco.
    Belayachi J; Obtel M; Mhayi A; Razine R; Abouqal R
    PLoS One; 2022; 17(12):e0278546. PubMed ID: 36477077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 vaccine effectiveness in preventing confirmed infection in pregnant women.
    Butt AA; Chemaitelly H; Al Khal A; Coyle PV; Saleh H; Kaleeckal AH; Latif AN; Bertollini R; Abou-Samra AB; Abu-Raddad LJ
    J Clin Invest; 2021 Dec; 131(23):. PubMed ID: 34618693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine coverage and effectiveness against laboratory-confirmed symptomatic and severe Covid-19 in indigenous people in Brazil: a cohort study.
    Pescarini JM; Cardoso AM; Santos RV; Scaff PF; Paixao ES; Ranzani OT; Cerqueira-Silva T; Boaventura VS; Bertoldo-Junior J; de Oliveira VA; Werneck GL; Barreto ML; Barral-Netto M
    BMC Public Health; 2023 Jun; 23(1):1267. PubMed ID: 37386490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness of primary series CoronaVac vaccine in preventing COVID-19 illness: A prospective cohort study among healthcare workers in Azerbaijan, May-November 2021.
    Katz MA; Rojas Castro MY; Seyidov N; Herdman MT; Mehdiyev S; McKnight CJ; Guseinova A; Cojocaru R; Doran J; Mühlemann B; Drosten C; Suleymanova J; Pebody R; Kissling E; Hagverdiyev G
    Influenza Other Respir Viruses; 2023 Oct; 17(10):e13147. PubMed ID: 37799775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of CoronaVac on Covid-19 outcomes of elderly adults in a large and socially unequal Brazilian city: A target trial emulation study.
    Monteiro HS; Lima Neto AS; Kahn R; Sousa GS; Carmona HA; Andrade JS; Castro MC
    Vaccine; 2023 Sep; 41(39):5742-5751. PubMed ID: 37573202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.